Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Sokol

Showing results (81-90 of 321) with videos related to

Pageof 33
Sort By:
Frontiers in Immunology|December 7, 2017
Probiotic Strain <i>Lactobacillus casei</i> BL23 Prevents Colitis-Associated Colorectal CancerElsa Jacouton, Florian Chain, Harry Sokol, et al.
Gut|March 6, 2012
Factors affecting outcomes in Crohn's disease over 15 yearsJacques Cosnes, Anne Bourrier, Isabelle Nion-Larmurier, et al.
Drug Discovery Today|June 21, 2020
Human microbial metabolite mimicry as a strategy to expand the chemical space of potential drugsHao Li, Harmit S Ranhotra, Sridhar Mani, et al.
Inflammatory Bowel Diseases|May 23, 2009
Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawalHarry Sokol, Philippe Seksik, Isabelle Nion-Larmurier, et al.
Journal of Crohn'S & Colitis|November 21, 2013
Crohn's disease of the vulvaMaximilien Barret, Vincent de Parades, Maxime Battistella, et al.
Pharmacology & Therapeutics|May 20, 2023
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?Matthieu Delaye, Adrien Rousseau, Léah Mailly-Giacchetti, et al.
Advances in Therapy|January 29, 2024
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?Dan Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Critical Reviews in Food Science and Nutrition|November 6, 2013
Impact of probiotics on risk factors for cardiovascular diseases. A reviewBruno Ebel, Guillaume Lemetais, Laurent Beney, et al.
Modern Rheumatology|May 19, 2022
On the determinants of IDO activity in patients with familial Mediterranean feverSamuel Deshayes, Jacques Callebert, Jean-Marie Launay, et al.
Journal of Hazardous Materials|September 20, 2024
Systemic inflammatory response to daily exposure to microcystin-LR and the underlying gut microbial mechanismsYanyan Zhao, Harry Sokol, Qing Cao, et al.
Pageof 33

Showing results (81-90 of 321) with videos related to

Sort By:
Pageof 33
Frontiers in Immunology|December 7, 2017
Probiotic Strain <i>Lactobacillus casei</i> BL23 Prevents Colitis-Associated Colorectal CancerElsa Jacouton, Florian Chain, Harry Sokol, et al.
Gut|March 6, 2012
Factors affecting outcomes in Crohn's disease over 15 yearsJacques Cosnes, Anne Bourrier, Isabelle Nion-Larmurier, et al.
Drug Discovery Today|June 21, 2020
Human microbial metabolite mimicry as a strategy to expand the chemical space of potential drugsHao Li, Harmit S Ranhotra, Sridhar Mani, et al.
Inflammatory Bowel Diseases|May 23, 2009
Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawalHarry Sokol, Philippe Seksik, Isabelle Nion-Larmurier, et al.
Journal of Crohn'S & Colitis|November 21, 2013
Crohn's disease of the vulvaMaximilien Barret, Vincent de Parades, Maxime Battistella, et al.
Pharmacology & Therapeutics|May 20, 2023
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?Matthieu Delaye, Adrien Rousseau, Léah Mailly-Giacchetti, et al.
Advances in Therapy|January 29, 2024
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?Dan Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Critical Reviews in Food Science and Nutrition|November 6, 2013
Impact of probiotics on risk factors for cardiovascular diseases. A reviewBruno Ebel, Guillaume Lemetais, Laurent Beney, et al.
Modern Rheumatology|May 19, 2022
On the determinants of IDO activity in patients with familial Mediterranean feverSamuel Deshayes, Jacques Callebert, Jean-Marie Launay, et al.
Journal of Hazardous Materials|September 20, 2024
Systemic inflammatory response to daily exposure to microcystin-LR and the underlying gut microbial mechanismsYanyan Zhao, Harry Sokol, Qing Cao, et al.
Pageof 33